Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CAMPCamp4 Therapeutics Corp

Nasdaq · CIK 0001736730
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts233

Identity from submissions API

NameCamp4 Therapeutics Corp
CIK0001736730
TickersCAMP
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-651-8867
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
100 TALCOTT AVENUE
SUITE 201
WATERTOWN
MA
02472
MA
Mailing address
100 TALCOTT AVENUE
SUITE 201
WATERTOWN
MA
02472
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

195 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-120150 005-94655 261555523 34 17102
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-127409 005-94655 261554942 34 19412
2026-11-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-007554 005-94655 261543891 34 15964
2026-11-05 10-Q 10-Q 0001628280-26-071054 001-42365 261527455 34 7022385 1 1
2026-11-05 8-K 8-K 9.01 0001628280-26-071050 001-42365 261527413 34 259732 1 1
2026-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002713 005-94655 261526121 34 11689
2026-09-28 8-K 8-K 7.01,8.01,9.01 0001628280-26-063740 001-42365 261417975 34 9248638 1 1
2026-09-02 4 FORM 4 0001628280-26-060234 6880
2026-08-31 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753037-26-000007 005-94655 261347471 34 20612
2026-08-31 4 xslF345X06/form4-08312026_090809.xml 0001598549-26-000011 7871
2026-08-26 4 xslF345X06/form4-08262026_080835.xml 0001598549-26-000009 7867
2026-08-21 4 xslF345X06/form4-08212026_080827.xml 0001598549-26-000007 12535
2026-08-19 4 FORM 4 0001628280-26-058107 5063
2026-08-19 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-357272 005-94655 261296841 34 22761
2026-08-19 144 xsl144X01/primary_doc.xml 0001974494-26-000263 001-42365 261293154 33 4767
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003419 005-94655 261275777 34 15967
2026-08-13 10-Q 10-Q 0001628280-26-056760 001-42365 261273864 34 6825844 1 1
2026-08-13 8-K 8-K 2.02,9.01 0001628280-26-056758 001-42365 261273830 34 262620 1 1
2026-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002650 333-298067 261269694 33 1754
2026-08-12 424B3 424B3 0001628280-26-056325 333-298067 261268517 33 697006
2026-08-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-036926 005-94655 261259738 34 23648
2026-08-06 S-3 S-3 0001628280-26-054389 333-298067 261249830 33 997034 1 1
2026-08-05 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001753037-26-000003 005-94655 261245077 34 22682
2026-08-05 4 xslF345X06/form4-08052026_090822.xml 0001231919-26-000829 17718
2026-08-05 4 xslF345X06/form4-08052026_090821.xml 0001598549-26-000002 6558
2026-08-05 4 FORM 4 0001628280-26-053513 5238
2026-08-05 4 FORM 4 0001628280-26-053512 5241
2026-08-05 4 FORM 4 0001628280-26-053511 5216
2026-08-05 4 FORM 4 0001628280-26-053505 5262
2026-08-04 8-K 8-K 1.01,3.02,7.01,9.01 0001628280-26-052150 001-42365 261235426 34 531467 1 1
2026-07-27 8-K 8-K 7.01,8.01,9.01 0001628280-26-049661 001-42365 261202794 34 209585 1 1
2026-06-12 4 FORM 4 0001628280-26-042863 5643
2026-06-12 4 FORM 4 0001628280-26-042862 5722
2026-06-12 4 FORM 4 0001628280-26-042861 5732
2026-06-12 4 FORM 4 0001628280-26-042860 5666
2026-06-12 4 FORM 4 0001628280-26-042859 5637
2026-06-12 4 FORM 4 0001628280-26-042858 5659
2026-06-12 8-K 8-K 5.02,5.07,9.01 0001628280-26-042846 001-42365 261086758 34 332122 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225173 005-94655 26982004 34 142228
2026-05-14 8-K 8-K 7.01,9.01 0001736730-26-000033 001-42365 26976112 34 3787683 1 1
2026-05-07 10-Q 10-Q 0001628280-26-032146 001-42365 26953625 34 5288010 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001628280-26-032096 001-42365 26953287 34 216460 1 1
2026-04-23 ARS ARS 0001736730-26-000030 001-42365 26885507 34 24592557
2026-04-23 DEFA14A DEFA14A 0001736730-26-000028 001-42365 26885500 34 1324463
2026-04-23 DEF 14A DEF 14A 0001736730-26-000026 001-42365 26885488 34 2764684 1 1
2026-04-03 4 FORM 4 0002089301-26-000003 5596
2026-04-03 4 FORM 4 0001881045-26-000002 5600
2026-04-03 4 FORM 4 0002033333-26-000002 5596
2026-04-03 4 FORM 4 0001927058-26-000002 5599
2026-04-03 4 FORM 4 0001383731-26-000006 5526
2026-04-03 3 FORM 3 0001383731-26-000004 10355
2026-03-24 8-K 8-K 5.02 0001736730-26-000021 001-42365 26784140 34 156660 1 1
2026-03-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001953107-26-000005 005-94655 26744741 34 10432
2026-03-05 S-8 S-8 0001736730-26-000018 333-294048 26726332 33 318210 1 1
2026-03-05 10-K 10-K 0001736730-26-000016 001-42365 26726155 34 12329054 1 1
2026-03-05 8-K 8-K 2.01,7.01,9.01 0001736730-26-000015 001-42365 26726115 34 3609181 1 1
2026-02-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-26-016645 005-94655 26635165 34 14199
2026-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000391 005-94655 26601849 34 11647
2026-01-09 8-K 8-K 7.01,9.01 0001736730-26-000004 001-42365 26523452 34 3553867 1 1
2026-01-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-26-000026 005-94655 26518311 34 10196
2025-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001953107-25-000021 005-94655 251601965 34 10114
2025-12-23 8-K 8-K 1.01,1.02 0001736730-25-000116 001-42365 251601510 34 153767 1 1
2025-12-22 4 FORM 4 0002089301-25-000004 5588
2025-12-22 4 FORM 4 0001881045-25-000005 5623
2025-12-22 4 FORM 4 0002033333-25-000005 5598
2025-12-22 4 FORM 4 0001927058-25-000004 5643
2025-12-18 8-K 8-K 1.01,9.01 0001628280-25-058009 001-42365 251583982 34 548104 1 1
2025-12-18 424B5 424B5 0001628280-25-058007 333-291432 251583952 33 446522
2025-12-18 FWP FWP 0001628280-25-057796 333-291432 251581246 34 40393
2025-12-18 8-K 8-K 1.01,7.01,9.01 0001736730-25-000111 001-42365 251581243 34 177991 1 1
2025-12-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-120225 005-94655 251564101 34 17533
2025-12-01 424B5 424B5 0001628280-25-054439 333-291432 251539797 33 359742
2025-11-25 424B3 424B3 0001736730-25-000102 333-291225 251521536 33 217515
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001656629-25-000005 005-94655 251488655 34 17847
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001869128-25-000004 005-94655 251487696 34 17960
2025-11-10 S-3 S-3 0001736730-25-000098 333-291432 251467364 33 1886833 1 1
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002916 005-94655 251461151 34 11647
2025-11-06 10-Q 10-Q 0001736730-25-000094 001-42365 251458602 34 6465781 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001736730-25-000092 001-42365 251458291 34 232076 1 1
2025-11-03 S-3 S-3 0001736730-25-000086 333-291225 251444302 33 503792 1 1
2025-10-10 3 FORM 3 0002089301-25-000002 15018
2025-10-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002314 005-94655 251379725 34 11544
2025-10-01 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-226248 005-94655 251363204 34 111344
2025-10-01 8-K 8-K 7.01,9.01 0001736730-25-000074 001-42365 251362634 34 174290 1 1
2025-09-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-088676 005-94655 251321290 34 14698
2025-09-16 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-004132 005-94655 251317779 34 17216
2025-09-15 4 xslF345X05/form4-09162025_120953.xml 0001598549-25-000004 7774
2025-09-15 4 xslF345X05/form4-09152025_100930.xml 0001231919-25-000196 18724
2025-09-15 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001953107-25-000007 005-94655 251315412 34 9509
2025-09-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-201410 005-94655 251309241 34 31099
2025-09-11 4 4 0001193125-25-201392 20148
2025-09-11 4 4 0001193125-25-201380 10430
2025-09-11 4 FORM 4 0001881045-25-000003 5062
2025-09-11 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001415889-25-024279 005-94655 251308808 34 33804
2025-09-11 4 FORM 4 0002033333-25-000003 5059
2025-09-11 4 FORM 4 0001927058-25-000002 5063
2025-09-11 4 FORM 4 0001490283-25-000003 5060
2025-09-10 8-K 8-K 1.01,3.02,5.02,7.01,9.01 0001736730-25-000072 001-42365 251304650 34 953087 1 1
2025-08-14 10-Q 10-Q 0001736730-25-000070 001-42365 251219537 34 5633513 1 1
2025-08-14 8-K 8-K 2.02,9.01 0001736730-25-000068 001-42365 251218987 34 220588 1 1
2025-06-27 4 FORM 4 0001736730-25-000061 5589
2025-06-27 4 FORM 4 0001736730-25-000060 5602
2025-06-27 4 FORM 4 0001736730-25-000059 5607
2025-06-27 4 FORM 4 0001736730-25-000058 5612
2025-06-27 4 FORM 4 0001736730-25-000057 5546
2025-06-27 4 FORM 4 0001736730-25-000056 5539
2025-06-27 4 FORM 4 0001736730-25-000055 5592
2025-06-27 4 FORM 4 0001736730-25-000054 5596
2025-06-13 8-K 8-K 5.07 0001736730-25-000043 001-42365 251046370 34 159716 1 1
2025-05-16 8-K 8-K 7.01,9.01 0001736730-25-000041 001-42365 25956874 34 5957720 1 1
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-071166 005-94655 25944320 34 143977
2025-05-13 10-Q 10-Q 0001736730-25-000039 001-42365 25940578 34 5287019 1 1
2025-05-13 8-K 8-K 2.02,9.01 0001736730-25-000037 001-42365 25940453 34 228928 1 1
2025-04-30 ARS ARS 0001736730-25-000029 001-42365 25890891 34 29994244
2025-04-30 DEFA14A DEFA14A 0001736730-25-000028 001-42365 25890884 34 1305906
2025-04-30 DEF 14A DEF 14A 0001736730-25-000027 001-42365 25890875 34 2476571 1 1
2025-04-11 3/A FORM 3/A 0001628280-25-017487 4000
2025-04-03 4 FORM 4 0001628280-25-016486 5463
2025-04-03 4 FORM 4 0001628280-25-016484 5460
2025-04-03 4 FORM 4 0001628280-25-016482 5456
2025-04-03 4 FORM 4 0001628280-25-016481 5462
2025-03-27 S-8 S-8 0001736730-25-000023 333-286172 25779569 33 99090
2025-03-27 10-K 10-K 0001736730-25-000022 001-42365 25779456 34 16049724 1 1
2025-03-27 8-K 8-K 2.02,9.01 0001736730-25-000021 001-42365 25779343 34 232438 1 1
2025-03-19 4 FORM 4 0001736730-25-000012 5373
2025-03-19 4 FORM 4 0001736730-25-000011 5384
2025-03-19 3 FORM 3 0001736730-25-000010 10504
2025-03-19 3 FORM 3 0001736730-25-000009 10302
2025-03-18 8-K 8-K 5.02 0001736730-25-000004 001-42365 25746539 34 168302 1 1
2025-01-07 8-K FORM 8-K 7.01,8.01,9.01 0001104659-25-001679 001-42365 25515048 34 10224338 1 1
2024-11-21 10-Q 10-Q 0001410578-24-002045 001-42365 241484690 34 8198902 1 1
2024-11-21 8-K FORM 8-K 2.02,9.01 0001104659-24-121533 001-42365 241484536 34 267333 1 1
2024-10-22 SC 13G SC 13G 0001104659-24-110632 005-94655 241387488 34 122184
2024-10-22 SC 13D SC 13D 0001193125-24-241180 005-94655 241387224 34 178625
2024-10-22 4/A 4/A 0000950170-24-116360 33550
2024-10-22 3/A 3/A 0000950170-24-116330 10078
2024-10-22 SC 13G SC 13G 0001104659-24-110572 005-94655 241386546 34 115899
2024-10-22 SC 13D SC 13D 0001104659-24-110570 005-94655 241386524 34 156313
2024-10-22 SC 13D SC 13D 0001104659-24-110566 005-94655 241386498 34 73035
2024-10-17 4 xslF345X05/form4-10172024_101042.xml 0001415889-24-025393 25368
2024-10-17 4 xslF345X05/form4-10172024_091016.xml 0001415889-24-025380 23333
2024-10-17 4 xslF345X05/form4-10172024_041001.xml 0001415889-24-025354 11468
2024-10-16 SEC STAFF LETTER filename1.pdf 9999999997-24-004124 64262
2024-10-16 S-8 FORM S-8 0001104659-24-109144 333-282676 241374654 33 286625
2024-10-15 4 4 0000950170-24-114788 32300
2024-10-15 4 xslF345X05/form4-10152024_091031.xml 0001415889-24-025140 23218
2024-10-15 4 OWNERSHIP DOCUMENT 0001104659-24-108703 24896
2024-10-15 4 OWNERSHIP DOCUMENT 0001104659-24-108702 18577
2024-10-15 4 OWNERSHIP DOCUMENT 0001104659-24-108701 7159
2024-10-15 4 OWNERSHIP DOCUMENT 0001104659-24-108700 7213
2024-10-15 4 OWNERSHIP DOCUMENT 0001104659-24-108699 7224
2024-10-15 3 3 0000950170-24-114773 8685
2024-10-15 8-K FORM 8-K 5.03,9.01 0001104659-24-108583 001-42365 241371901 34 361833 1 1
2024-10-11 424B4 424B4 0001104659-24-108067 333-282241 241367918 33 5170919
2024-10-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-10-10 16:00:00 9999999995-24-003151 333-282241 241366237 33 1775
2024-10-10 3 3 0000950170-24-114172 13631
2024-10-10 3 xslF345X02/form3-10112024_011037.xml 0001415889-24-025000 7329
2024-10-10 3 xslF345X02/form3-10112024_011040.xml 0001415889-24-024998 14468
2024-10-10 3 xslF345X02/form3-10112024_011015.xml 0001415889-24-024996 18360
2024-10-10 3 xslF345X02/form3-10112024_011012.xml 0001415889-24-024994 15502
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107821 11428
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107820 21787
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107819 20481
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107818 17492
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107817 15452
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107816 19401
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107815 14162
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107814 10894
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107813 13802
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107812 12901
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107811 12263
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107810 15136
2024-10-10 3 OWNERSHIP DOCUMENT 0001104659-24-107809 10417
2024-10-10 CERT 8A_Cert_CAMP.pdf 0001354457-24-000756 001-42365 241364738 34 761134
2024-10-08 8-A12B FORM 8-A12B 0001104659-24-107031 001-42365 241360346 34 17121
2024-10-08 CORRESP filename1.htm 0001104659-24-107027 13664
2024-10-08 CORRESP filename1.htm 0001104659-24-107025 10735
2024-10-07 S-1/A S-1/A 0001104659-24-106393 333-282241 241356027 33 5820809
2024-10-02 CORRESP filename1.htm 0001104659-24-105457 18239
2024-10-02 UPLOAD filename1.pdf 0000000000-24-011137 377-07276 43157
2024-09-26 S-1/A S-1/A 0001104659-24-103141 333-282241 241329071 33 5651190
2024-09-20 S-1 S-1 0001104659-24-101618 333-282241 241312771 33 6934837
2024-08-22 DRSLTR filename1.htm 0001104659-24-091973 21149
2024-08-22 DRS/A filename1.htm 0001104659-24-091970 377-07276 241231772 33 5238569
2024-08-15 SEC STAFF LETTER filename1.pdf 9999999997-24-003612 65104
2024-08-13 UPLOAD filename1.pdf 0000000000-24-009257 377-07276 43549
2024-08-02 DRS/A filename1.htm 0001104659-24-084997 377-07276 241168164 33 5451510
2024-07-26 DRSLTR filename1.htm 0001104659-24-083071 90150
2024-07-26 DRS/A filename1.htm 0001104659-24-083069 377-07276 241148048 33 4737471
2024-07-15 UPLOAD filename1.pdf 0000000000-24-007983 377-07276 66396
2024-06-14 DRS filename1.htm 0001104659-24-071596 377-07276 241043626 33 4920032
2022-06-21 D xslFormDX01/primary_doc.xml 06b 0001736730-22-000003 021-449708 221026753 33 19310
2021-10-29 D/A xslFormDX01/primary_doc.xml 06b 0001736730-21-000002 021-392937 211363177 33 17633
2021-03-19 D xslFormDX01/primary_doc.xml 06b 0001736730-21-000001 021-392937 21758700 33 14210
2018-09-25 D xslFormDX01/primary_doc.xml 06b 0001736730-18-000001 021-322125 181085715 33 9240

Latest XBRL company facts

One latest value per concept from companyfacts (233 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 62.75M 2026-11-04 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
dei EntityPublicFloat Entity Public Float USD 14.60M 2025-06-30 2025 FY 10-K 2026-03-05 0001736730-26-000016
ffd NetFeeAmt NetFeeAmt USD 15,544.65 2026-08-06 S-3 2026-08-06 0001628280-26-054389
ffd TtlFeeAmt TtlFeeAmt USD 15,544.65 2026-08-06 S-3 2026-08-06 0001628280-26-054389
ffd TtlOfferingAmt TtlOfferingAmt USD 112.56M 2026-08-06 S-3 2026-08-06 0001628280-26-054389
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-06 S-3 2026-08-06 0001628280-26-054389
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-06 S-3 2026-08-06 0001628280-26-054389
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 760,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 1.00M 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 6.98M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 652,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 7.57M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 480.06M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.02M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.04M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 90.19M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap Assets Assets USD 134.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap AssetsCurrent Assets, Current USD 127.54M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 101,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap Cash Cash USD 100,000 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 124.52M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 117.57M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 126.15M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 14.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 142 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 43.92M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 175.00M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 62.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 62.75M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap CommonStockValue Common Stock, Value, Issued USD 7,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -80.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 10.50M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 106,000 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 1.00M 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 76.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 15.39M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 33.79M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 2.53M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 12.27M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 76.14M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 106,000 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DepositsAssets Deposits Assets USD 2.20M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 1.30M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD -44.76M 2025-12-31 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap DividendsPreferredStockCash Dividends, Preferred Stock, Cash USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.24 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.153 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 231,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.007 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.068 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.03 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 2.55M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 15.40M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings USD -42.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Issues USD -14.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements USD 87.69M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 6,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 93,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 74,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 27,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 47,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 80,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 31,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 31,000 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 31,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 18,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 6,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 90,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 46,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.077 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap ForwardContractIndexedToIssuersEquitySettlementAlternativesCashAtFairValue Forward Contract Indexed to Issuer's Equity, Settlement Alternatives, Cash, at Fair Value USD 50.10M 2026-08-03 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -42.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -98,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 316,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 13.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 12.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -164,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -16.89M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 554,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 2.28M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 565,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -4.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 624,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -947,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.42M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 167,000 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 964,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.89M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 322,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 975,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap Liabilities Liabilities USD 26.92M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 134.01M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap LiabilitiesCurrent Liabilities, Current USD 19.86M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 47.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -869,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -31.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -80.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -80.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -80.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NoninterestExpenseOfferingCost Noninterest Expense Offering Cost USD 5.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -40.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingExpenses Operating Expenses USD 45.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -40.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseCost Operating Lease, Cost USD 410,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.88M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 89,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.45M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 4.83M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeasePayments Operating Lease, Payments USD 371,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 314,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.077 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 173,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherAssetsCurrent Other Assets, Current USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 61,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 27,000 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 49,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 192,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -108,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 3,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap PaymentsOfDividendsPreferredStockAndPreferenceStock Payments of Ordinary Dividends, Preferred Stock and Preference Stock USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 869,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 11.65M 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.06 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap PreferredStockDividendsPerShareDeclared Preferred Stock, Dividends Per Share, Declared USD/shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-10-15 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2024-10-15 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 2.29M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PrepaidInsurance Prepaid Insurance USD 26,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ProceedsFromDerivativeInstrumentFinancingActivities Proceeds from Derivative Instrument, Financing Activities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 15.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 32.56M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 31.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 72.40M 2024-11-01 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 3,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -38.51M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-21 0001410578-24-002045
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization USD 1.68M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization USD 4.85M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 10.46M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 2.90M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 32.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RestrictedCash Restricted Cash USD 1.60M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 730,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 894,000 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -372.97M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.15M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-06 0001736730-25-000094
us-gaap Revenues Revenues USD 4.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 290,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001736730-25-000070
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 15,943 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 1.75 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.62M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.39 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 213,352 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 3.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.31M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 4.38M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.39 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 7.11 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.31M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 4.38M 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.12 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 6.26 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 5.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 43,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 107.09M 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.089 2024-10-03 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap StockIssued1 Stock Issued USD 28.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 45,970 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 24,128 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 162.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 113,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 44.41M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 4,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 25.00M 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-12-31 2024 FY 10-K 2025-03-27 0001736730-25-000022
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-14 0001736730-25-000070
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 11.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001736730-26-000016
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 65.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 65.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-05 0001628280-26-071054

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →